Stem Cell Research

Papers
(The TQCC of Stem Cell Research is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-06-01 to 2023-06-01.)
ArticleCitations
Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells163
Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis126
Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells125
Astroglial cells regulate the developmental timeline of human neurons differentiated from induced pluripotent stem cells111
Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells110
Cortical lesion stimulates adult subventricular zone neural progenitor cell proliferation and migration to the site of injury100
Insulin-like growth factor 1 can promote the osteogenic differentiation and osteogenesis of stem cells from apical papilla97
Dystrophin-deficient cardiomyocytes derived from human urine: New biologic reagents for drug discovery96
EZ spheres: A stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs95
Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients91
Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs90
Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts90
Hepatocyte-like cells differentiated from human induced pluripotent stem cells: Relevance to cellular therapies87
Genome-wide analysis of gene expression during adipogenesis in human adipose-derived stromal cells reveals novel patterns of gene expression during adipocyte differentiation84
Derivation of insulin-producing cells from human embryonic stem cells82
Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells80
Effects of FGF2 and oxygen in the BMP4-driven differentiation of trophoblast from human embryonic stem cells73
Enumeration of the colony-forming units–fibroblast from mouse and human bone marrow in normal and pathological conditions72
Optimized procedures for generating an enhanced, near physiological 2D culture system from porcine intestinal organoids70
One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells66
The HOX Code as a “biological fingerprint” to distinguish functionally distinct stem cell populations derived from cord blood65
Satellite cells from dystrophic muscle retain regenerative capacity63
DLK1(PREF1) is a negative regulator of adipogenesis in CD105+/CD90+/CD34+/CD31−/FABP4− adipose-derived stromal cells from subcutaneous abdominal fat pats of adult women62
Osteogenic differentiation of mesenchymal stem cells from dental bud: Role of integrins and cadherins59
Production of live fish derived from frozen germ cells via germ cell transplantation58
L-WRN conditioned medium for gastrointestinal epithelial stem cell culture shows replicable batch-to-batch activity levels across multiple research teams58
Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells57
Generation of functional podocytes from human induced pluripotent stem cells56
Update on fertility restoration from prepubertal spermatogonial stem cells: How far are we from clinical practice?56
Rapid and efficient differentiation of functional motor neurons from human iPSC for neural injury modelling55
Efficient and high yield isolation of myoblasts from skeletal muscle54
Generation of non-transgenic iPS cells from human cord blood CD34 + cells under animal component-free conditions54
Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening52
Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders51
Production and isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium51
New potential cell source for hepatocyte transplantation: Discarded livers from metabolic disease liver transplants44
Accelerated photoreceptor differentiation of hiPSC-derived retinal organoids by contact co-culture with retinal pigment epithelium44
The negative impact of Wnt signaling on megakaryocyte and primitive erythroid progenitors derived from human embryonic stem cells43
Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress42
Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: Rescue by chondrogenic pre-induction40
Patch-clamp recordings and calcium imaging followed by single-cell PCR reveal the developmental profile of 13 genes in iPSC-derived human neurons40
Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming40
Generation of tissue-specific cells from MSC does not require fusion or donor-to-host mitochondrial/membrane transfer39
Enhanced chondrogenesis from human embryonic stem cells37
Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN137
High fat diet promotes prostatic basal-to-luminal differentiation and accelerates initiation of prostate epithelial hyperplasia originated from basal cells36
Adipose-derived stem cells from the brown bear (Ursus arctos) spontaneously undergo chondrogenic and osteogenic differentiation in vitro36
Generating GABAergic cerebral cortical interneurons from mouse and human embryonic stem cells36
Hopx distinguishes hippocampal from lateral ventricle neural stem cells36
Potential therapeutic roles of stem cells in ischemia-reperfusion injury35
Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro35
Isolation and comparative analysis of potential stem/progenitor cells from different regions of human umbilical cord35
Differentiation of neural rosettes from human pluripotent stem cells in vitro is sequentially regulated on a molecular level and accomplished by the mechanism reminiscent of secondary neurulation34
BMP inhibition stimulates WNT-dependent generation of chondrogenic mesoderm from embryonic stem cells33
Rapid generation of sub-type, region-specific neurons and neural networks from human pluripotent stem cell-derived neurospheres32
WNT and BMP signaling are both required for hematopoietic cell development from human ES cells32
Bidirectional induction toward paraxial mesodermal derivatives from mouse ES cells in chemically defined medium32
Adipose-derived stromal cell secretome reduces TNFα-induced hypertrophy and catabolic markers in primary human articular chondrocytes32
Characterization of neurons from immortalized dental pulp stem cells for the study of neurogenetic disorders32
A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells32
Generation of male germ cells from mouse induced pluripotent stem cells in vitro31
Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line31
Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes31
Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host disease30
Generation of organized anterior foregut epithelia from pluripotent stem cells using small molecules30
Generation of iPSC line HEL24.3 from human neonatal foreskin fibroblasts30
Efficient definitive endoderm induction from mouse embryonic stem cell adherent cultures: A rapid screening model for differentiation studies30
Derivation of human iPS cell lines from monozygotic twins in defined and xeno free conditions29
Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN28
Human neural progenitors derived from integration-free iPSCs for SCI therapy28
Cardiac regeneration in vivo: Mending the heart from within?28
Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 128
Generation of functional neurons and glia from multipotent adult mouse germ-line stem cells27
Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation27
Generation of retinal pigment epithelial cells from human embryonic stem cell-derived spherical neural masses26
The role of nuclear receptors in the differentiation of oligodendrocyte precursor cells derived from fetal and adult neural stem cells26
Mammospheres from murine mammary stem cell-enriched basal cells: Clonal characteristics and repopulating potential26
Characterization and application of electrically active neuronal networks established from human induced pluripotent stem cell-derived neural progenitor cells for neurotoxicity evaluation25
Dendritic cells and M2 macrophage play an important role in suppression of Th2-mediated inflammation by adipose stem cells-derived extracellular vesicles25
Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line24
The adipose tissue of origin influences the biological potential of human adipose stromal cells isolated from mediastinal and subcutaneous fat depots24
Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology24
In vitro culture and characterization of putative porcine embryonic germ cells derived from domestic breeds and Yucatan mini pig embryos at Days 20–24 of gestation24
Permeability analyses and three dimensional imaging of interferon gamma-induced barrier disintegration in intestinal organoids24
Induced pluripotent stem cells (iPSC) created from skin fibroblasts of patients with Prader-Willi syndrome (PWS) retain the molecular signature of PWS23
Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes23
Skeletal-muscle-derived mesenchymal stem/stromal cells from patients with osteoarthritis show superior biological properties compared to bone-derived cells23
Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors23
Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs23
Extracellular vesicles released by adipose tissue-derived mesenchymal stromal/stem cells from obese pigs fail to repair the injured kidney23
Endothelial cells provide a niche for placental hematopoietic stem/progenitor cell expansion through broad transcriptomic modification23
Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-122
Multiple mechanisms mediate the taurine-induced proliferation of neural stem/progenitor cells from the subventricular zone of the adult mouse22
ROCK inhibitor increases proacinar cells in adult salivary gland organoids22
MicroRNA-29a promotes smooth muscle cell differentiation from stem cells by targeting YY122
Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-1022
Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults22
Pyrimidoindole derivative UM171 enhances derivation of hematopoietic progenitor cells from human pluripotent stem cells22
Generation of urine iPS cell lines from patients with Attention Deficit Hyperactivity Disorder (ADHD) using a non-integrative method22
The evolution of Great Apes has shaped the functional enhancers' landscape in human embryonic stem cells22
Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localizatio21
Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts21
Sonic hedgehog released from scratch-injured astrocytes is a key signal necessary but not sufficient for the astrocyte de-differentiation20
Detection of all adult Tau isoforms in a 3D culture model of iPSC-derived neurons20
Neural stem cell isolation from the whole mouse brain using the novel FABP7-binding fluorescent dye, CDr320
Regulation of the tenogenic gene expression in equine tenocyte-derived induced pluripotent stem cells by mechanical loading and Mohawk20
MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma20
Generation of pure monocultures of human microglia-like cells from induced pluripotent stem cells20
Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system20
Accumulation of mtDNA variations in human single CD34+ cells from maternally related individuals: Effects of aging and family genetic background19
Chorionic and amniotic membrane-derived stem cells have distinct, and gestational diabetes mellitus independent, proliferative, differentiation, and immunomodulatory capacities19
A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133+ stem/progenitor cells19
A pilgrim's progress: Seeking meaning in primordial germ cell migration19
Heat shock instructs hESCs to exit from the self-renewal program through negative regulation of OCT4 by SAPK/JNK and HSF1 pathway19
Electron transport chain complex II sustains high mitochondrial membrane potential in hematopoietic stem and progenitor cells19
Generation of a human iPSC line from a patient with Leigh syndrome18
CD133+ cells derived from skeletal muscles of Duchenne muscular dystrophy patients have a compromised myogenic and muscle regenerative capability18
CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response18
Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene18
Generation of human control iPS cell line CHOPWT10 from healthy adult peripheral blood mononuclear cells18
Generation of integration free induced pluripotent stem cells from fibrodysplasia ossificans progressiva (FOP) patients from urine samples18
GDNF enhances the anti-inflammatory effect of human adipose-derived mesenchymal stem cell-based therapy in renal interstitial fibrosis18
Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 118
Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells17
Reproducible and efficient generation of functionally active neurons from human hiPSCs for preclinical disease modeling17
Reduction in the inflammatory markers CD4, IL-1, IL-6 and TNFα in dogs with keratoconjunctivitis sicca treated topically with mesenchymal stem cells17
Association of Rex-1 to target genes supports its interaction with Polycomb function17
GASZ promotes germ cell derivation from embryonic stem cells17
Elimination of tumorigenic stem cells from differentiated progeny and selection of definitive endoderm reveals a Pdx1+ foregut endoderm stem cell lineage17
Electrophysiological properties of neurosensory progenitors derived from human embryonic stem cells17
Analysis of mesenchymal cells (MSCs) from bone marrow, synovial fluid and mesenteric, neck and tail adipose tissue sources from equines17
Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN117
Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient17
A critical role of CXCR2 PDZ-mediated interactions in endothelial progenitor cell homing and angiogenesis17
The crucial role of vitamin C and its transporter (SVCT2) in bone marrow stromal cell autophagy and apoptosis16
Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction16
Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha ( HNF1A ) mutation16
Alterations in genetic and protein content of swine adipose tissue-derived mesenchymal stem cells in the metabolic syndrome16
Hepatocyte-like cells derived from human amniotic epithelial, bone marrow, and adipose stromal cells display enhanced functionality when cultured on decellularized liver substrate16
Differentiation of serum-free embryoid bodies from human induced pluripotent stem cells into networks15
Derivation of keratinocytes from chicken embryonic stem cells: Establishment and characterization of differentiated proliferative cell populations15
Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation15
NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells15
Endocrine cells develop within pancreatic bud-like structures derived from mouse ES cells differentiated in response to BMP4 and retinoic acid15
Immediate expression of Cdh2 is essential for efficient neural differentiation of mouse induced pluripotent stem cells15
Lessons from development: A role for asymmetric stem cell division in cancer14
Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers14
Pluripotent stem cell-derived interneuron progenitors mature and restore memory deficits but do not suppress seizures in the epileptic mouse brain14
Robust induction of retinal pigment epithelium cells from human induced pluripotent stem cells by inhibiting FGF/MAPK signaling14
Paracrine mechanisms in early differentiation of human pluripotent stem cells: Insights from a mathematical model14
In vitro characterization of bone marrow stromal cells from osteoarthritic donors14
Evaluation of commonly used ectoderm markers in iPSC trilineage differentiation14
Alpha7 nicotinic acetylcholine receptors and neural network synaptic transmission in human induced pluripotent stem cell-derived neurons14
Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control14
BDNF profoundly and specifically increases KCNQ4 expression in neurons derived from embryonic stem cells14
Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52 bp deletion 14
Post-Passage rock inhibition induces cytoskeletal aberrations and apoptosis in Human embryonic stem cells14
Primary cilium-associated genes mediate bone marrow stromal cell response to hypoxia14
Lymphoblastoids cell lines – Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG) 200 expansion in the DMPK gene: CHUQi001-A14
CD133-enriched Xeno-Free human embryonic-derived neural stem cells expand rapidly in culture and do not form teratomas in immunodeficient mice13
Generation of integration-free induced pluripotent stem cells from a patient with Familial Mediterranean Fever (FMF)13
Exosomes from 3D culture of marrow stem cells enhances endothelial cell proliferation, migration, and angiogenesis via activation of the HMGB1/AKT pathway13
Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells13
Generation of patient-specific induced pluripotent stem cells from Leber's hereditary optic neuropathy13
Establishment of human induced trophoblast stem-like cells from term villous cytotrophoblasts13
Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene13
Differentiation of glutamatergic neurons from mouse embryonic stem cells requires raptor S6K signaling13
Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue13
Pluripotency of embryo-derived stem cells from rodents, lagomorphs, and primates: Slippery slope, terrace and cliff13
Generation of two human isogenic iPSC lines from fetal dermal fibroblasts13
Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses13
Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions13
Linking substrate and nucleus via actin cytoskeleton in pluripotency maintenance of mouse embryonic stem cells13
Derivation and characterization of putative craniofacial mesenchymal progenitor cells from human induced pluripotent stem cells12
GMP-compatible manufacturing of three iPS cell lines from human peripheral blood12
In vivo regeneration of rat laryngeal cartilage with mesenchymal stem cells derived from human induced pluripotent stem cells via neural crest cells12
Pharmacological exposures may precipitate craniosynostosis through targeted stem cell depletion12
Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy12
Generation and characterization of a human iPSC line from a patient with propionic acidemia due to defects in the PCCA gene12
Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery12
Neural stem cells derived from epiblast stem cells display distinctive properties12
Generation of HEXA -deficient hiPSCs from fibroblasts of a Tay-Sachs disease patient12
Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene12
Cyclic tensile stress promotes osteogenic differentiation of adipose stem cells via ERK and p38 pathways12
Small molecule AT7867 proliferates PDX1-expressing pancreatic progenitor cells derived from human pluripotent stem cells12
Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q 10 deficiency harboring a heterozygous mutation in COQ4 gene12
Prolactin hormone exerts anti-tumorigenic effects in HER-2 overexpressing breast cancer cells through regulation of stemness12
Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with lymphedema-distichiasis syndrome (LDS) carrying an insertion–deletion complex mutation in the FOXC2 gen11
Generation of an iPSC line from a patient with GTP cyclohydrolase 1 ( GCH1 ) deficiency: HDMC0061i-GCH111
Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines11
Reporter gene-engineering of human induced pluripotent stem cells during differentiation renders in vivo traceable hepatocyte-like cells accessible11
Generation of an induced pluripotent stem cell (iPSC) line from a 40-year-old patient with the A8344G mutation of mitochondrial DNA and MERRF (myoclonic epilepsy with ragged red fibers) syndrome11
Generation of a human iPSC line from a patient with Leigh syndrome caused by a mutation in the MT-ATP6 gene11
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation11
Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN111
Efficient generation of pancreatic β-like cells from the mouse gallbladder11
Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells11
In vivo fate of bone marrow mesenchymal stem cells implanted into rat pulpotomized molars11
Stem cell passage affects directional migration of stem cells in electrotaxis11
Generation of iPS cell lines from schizophrenia patients using a non-integrative method11
Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene11
Differentiation and characterization of rhesus monkey atrial and ventricular cardiomyocytes from induced pluripotent stem cells11
Generation of human induced pluripotent stem cells from urinary cells of a healthy donor using a non-integration system11
Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A11
Efficient induction of inner ear hair cell-like cells from mouse ES cells using combination of Math1 transfection and conditioned medium from ST2 stromal cells11
The in vivo timeline of differentiation of engrafted human neural progenitor cells11
Simulated microgravity-cultured mesenchymal stem cells improve recovery following spinal cord ischemia in rats11
Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 193611
Establishment of PSEN1 mutant induced pluripotent stem cell (iPSC) line from an Alzheimer's disease (AD) female patient11
Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene11
Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutation10
Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapies10
Induced pluripotent stem cells derived from a schizophrenia patient with ASTN2 deletion10
Generation of iPSC line HEL47.2 from healthy human adult fibroblasts10
Fancd2-deficient hematopoietic stem and progenitor cells depend on augmented mitochondrial translation for survival and proliferation10
Endothelial cells instruct liver specification of embryonic stem cell-derived endoderm through endothelial VEGFR2 signaling and endoderm epigenetic modifications10
Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons10
Establishment of induced pluripotent stem cell (iPSC) line from a 57-year old patient with sporadic Alzheimer's disease10
Generation of skeletal myogenic progenitors from human pluripotent stem cells using non-viral delivery of minicircle DNA10
Generation of iPSC lines from two patients affected by febrile seizure due to inherited missense mutation in SCN1A gene10
Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain ( MYH7 ) gene10
Collaboration between WNT and BMP signaling promotes hemoangiogenic cell development from human fibroblast-derived iPS cells10
Analysis of lacrimal gland derived mesenchymal stem cell secretome and its impact on epithelial cell survival10
Deploying human pluripotent stem cells to treat central nervous system disorders: facts, challenges and realising the potential10
Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47)10
Generation of an induced pluripotent stem cell line (TRNDi003-A) from a Noonan syndrome with multiple lentigines (NSML) patient carrying a p.Q510P mutation in the PTPN11 gene10
Generation of induced pluripotent stem cells from peripheral blood CD34 + hematopoietic progenitors of a 31 year old healthy woman10
Generation of a pig induced pluripotent stem cell (piPSC) line from embryonic fibroblasts by incorporating LIN28 to the four transcriptional factor-mediated reprogramming: VSMUi001-D10
Isolation, characterization, and differentiation of multipotent neural progenitor cells from human cerebrospinal fluid in fetal cystic myelomeningocele10
Peripheral blood mononuclear cell-converted induced pluripotent stem cells (iPSCs) from an early onset Alzheimer's patient10
Isolation of PRRX1-positive adult pituitary stem/progenitor cells from the marginal cell layer of the mouse anterior lobe10
Identification of suitable reference genes in bone marrow stromal cells from osteoarthritic donors10
Metabolic flux analyses to assess the differentiation of adult cardiac progenitors after fatty acid supplementation10
Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 310
Transplanted motoneurons derived from human induced pluripotent stem cells form functional connections with target muscle10
Reprogramming of Human Peripheral Blood Mononuclear Cell (PBMC) from a patient suffering of a Werner syndrome resulting in iPSC line (REGUi003-A) maintaining a short telomere length10
Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A310
CD71high population represents primitive erythroblasts derived from mouse embryonic stem cells10
Induced neural stem cells from distinct genetic backgrounds exhibit different reprogramming status9
Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease9
Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer's disease PSEN1 A246E patient and a non-demented family member bearing wild-type PSEN19
Generation and characterization of iPSC lines (BGUi004-A, BGUi005-A) from two identical twins with polyalanine expansion in the paired-like homeobox 2B (PHOX2B) gene9
Induced pluripotent stem cells (iPSCs) derived from frontotemporal dementia patient's peripheral blood mononuclear cells9
Constitutive activation of Notch2 signalling confers chemoresistance to neural stem cells via transactivation of fibroblast growth factor receptor-19
Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, memb9
An induced pluripotent stem cell line (TRNDi009-C) from a Niemann-Pick disease type A patient carrying a heterozygous p.L302P (c.905 T>C) mutation in the SMPD1 gene9
Generation of two isogenic human induced pluripotent stem cell lines from a 15 year-old female patient with MERRF syndrome and A8344G mutation of mitochondrial DNA9
Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 ( Rumi )9
Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder9
A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A9
Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts9
Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene9
Generation of a human iPSC line, FINCBi001-A, carrying a homoplasmic m.G3460A mutation in MT-ND1 associated with Leber’s Hereditary optic Neuropathy (LHON)9
Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient9
Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations9
Generation of human iPSC line from a patient with laterality defects and associated congenital heart anomalies carrying a DAND5 missense alteration9
Cryosectioning the intestinal crypt-villus axis: An ex vivo method to study the dynamics of epigenetic modifications from stem cells to differentiated cells9
Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene9
Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD)9
Generation of iPSC line MU011.A-hiPS from homozygous α-thalassemia fetal skin fibroblasts9
Characterization of stem cells associated with seminiferous tubule of adult rat testis for their potential to form Leydig cells9
Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family9
Generation of a human induced pluripotent stem cell line (BIHi002-A) from a patient with CLCN7-related infantile malignant autosomal recessive osteopetrosis9
Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 29
Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using an integration free vector8
Generation of an induced pluripotent stem cell line from chorionic villi of a Turner syndrome spontaneous abortion8
Blebbistatin protects iPSC-CMs from hypercontraction and facilitates automated patch-clamp based electrophysiological study8
Transcriptomic profiling of porcine pluripotency identifies species-specific reprogramming requirements for culturing iPSCs8
Hiding inside? Intracellular expression of non-glycosylated c-kit protein in cardiac progenitor cells8
Generation of patient-specific induced pluripotent stem cell lines from one patient with Jervell and Lange-Nielsen syndrome, one with type 1 long QT syndrome and two healthy relatives8
Generation of two compound heterozygous HGSNAT-mutated lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo C syndrome8
Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS)8
Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome8
Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells8
Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutation8
Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia8
Generation of urine-derived iPS cell line via a non-integrative method from a Barth syndrome patient with TAZ gene mutation8
Comparative transcriptomic analysis of endothelial progenitor cells derived from umbilical cord blood and adult peripheral blood: Implications for the generation of induced pluripotent stem cells8
Generation of striatal neurons from human induced pluripotent stem cells by controlling extrinsic signals with small molecules8
Adipose-derived stem cells undergo differentiation after co-culture with porcine limbal epithelial stem cells8
The mesenchymal transcription factor SNAI-1 instructs human liver specification8
Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene8
Generation of a human iPSC line from a patient with an optic atrophy ‘plus’ phenotype due to a mutation in the OPA1 gene8
Generation of an isogenic, gene-corrected iPSC line from a symptomatic 59-year-old female patient with frontotemporal dementia caused by an R406W mutation in the microtubule associated protein tau (MA8
Receptor interacting protein kinase 3 (RIP3) regulates iPSCs generation through modulating cell cycle progression genes8
Establishment of induced pluripotent stem cell (iPSC) line from a 75-year old patient with late onset Alzheimer's disease (LOAD)8
An integration-free, virus-free rhesus macaque induced pluripotent stem cell line (riPSC89) from embryonic fibroblasts8
Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G > A mutation in RB1 gene8
Computer-Aided 2D and 3D quantification of human stem cell fate from in vitro samples using Volocity high performance image analysis software8
Induced pluripotent stem cell line UOMi002-A from a patient with Leigh syndrome with compound heterozygous mutations in the NDUFV1 gene8
Generation of iPSC lines from primary human amniotic fluid cells8
GA-binding protein GABPβ1 is required for the proliferation of neural stem/progenitor cells8
Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene8
Xenogen-free isolation and culture of human adipose mesenchymal stem cells8
A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene8
Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS)8
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation8
Lymphoblast-derived integration-free iPSC lines from a female and male Alzheimer's disease patient expressing different copy numbers of a coding CNV in the Alzheimer risk gene CR18
Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55)8
Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients8
Simple methods for generating neural, bone and endodermal cell types from chick embryonic stem cells8
Generation of Cdx2-mCherry knock-in murine ES cell line to model trophectoderm and intestinal lineage differentiation7
Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 17
Generation of iPSC line (USTCi001-A) from human skin fibroblasts of a patient with epilepsy7
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA)7
Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene7
Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease7
Lymphoblast-derived integration-free iPS cell line from a 69-year-old male7
Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations7
Episomal plasmid-based generation of induced pluripotent stem cells from fetal femur-derived human mesenchymal stromal cells7
Development of FGF2-dependent pluripotent stem cells showing naive state characteristics from murine preimplantation inner cell mass7
An integration-free, virus-free rhesus macaque induced pluripotent stem cell line (riPSC90) from embryonic fibroblasts7
A naked mole rat iPSC line expressing drug-inducible mouse pluripotency factors developed from embryonic fibroblasts7
Generation of an integration-free induced pluripotent stem cell line (UNC001-A) from blood of a healthy individual7
Establishment and characterization of two iPSC lines derived from healthy controls7
Lymphoblast-derived integration-free iPS cell line from a 65-year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant7
Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis7
Human amniotic epithelial cells as feeder layer to derive and maintain human embryonic stem cells from poor-quality embryos7
Generation of a human iPS cell line (CGMH.SLC26A4919-2) from a Pendred syndrome patient carrying SLC26A4 c.919-2A>G splice-site mutation7
Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation7
Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR17
Generation of induced pluripotent stem cells (ARO-iPSC1-11) from a patient with autosomal recessive osteopetrosis harboring the c.212 + 1G > T mutation in SNX10 gene7
Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation7
Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder7
Establishment of a human induced pluripotent stem cell (iPSC) line (HIHDNEi002-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Arg297Gln) mutation7
Generation and genetic repair of two human induced pluripotent cell lines from patients with Epidermolysis Bullosa simplex and dilated cardiomyopathy associated with a heterozygous mutation in the tra7
Derivation of neural stem cells from human teratomas7
Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutatio7
Establishment and characterization of an iPSC line from a 58 years old high grade patient with nonalcoholic fatty liver disease (70% steatosis) with homozygous wildtype PNPLA3 genotype7
Transcription factor overexpression drives reliable differentiation of retinal pigment epithelium from human induced pluripotent stem cells7
Generation of sibling-matched induced pluripotent stem cell lines from spinal and bulbar muscular atrophy patients7
Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy7
Generation of an isogenic, gene-corrected iPSC line from a symptomatic 57-year-old female patient with frontotemporal dementia caused by a P301L mutation in the microtubule associated protein tau (MAP7
Generation of three human induced pluripotent stem cell sublines (MZT04D, MZT04J, MZT04C) for reproductive science research7
Generation of a human iPSC line from a patient with a mitochondrial encephalopathy due to mutations in the GFM1 gene7
Effects of reprogramming on genomic imprinting and the application of pluripotent stem cells7
Generation and characterization of the human iPSC line PBMC1-iPS4F1 from adult peripheral blood mononuclear cells7
Derivation of functional ventricular cardiomyocytes using endogenous promoter sequence from murine embryonic stem cells7
Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation7
Generation of induced pluripotent stem cells (iPSCs) from a Bernard–Soulier syndrome patient carrying a W71R mutation in the GPIX gene7
Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3 -associated retinal degeneration and a coisogenic control line7
Generation of induced pluripotent stem cell line RCPCMi008-A derived from patient with spinocerebellar ataxia 177
Derivation of an induced pluripotent stem cell line (MUSIi004-A) from dermal fibroblasts of a 48-year-old spinocerebellar ataxia type 3 patient7
Generation of an induced pluripotent stem cell (iPSC) line, DHMCi005-A, from a patient with CALFAN syndrome due to mutations in SCYL17
Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog7
Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs*5 mutation in MERTK7
Induced pluripotent stem cell line MUSIi006-A derived from hair follicle keratinocytes as a non-invasive somatic cell source7
Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5)7
Pluripotent pig embryonic stem cell lines originating from in vitro-fertilized and parthenogenetic embryos7
Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC7
Generation of iPSC line epiHUVEC from human umbilical vein endothelial cells7
Induction of rod versus cone photoreceptor-specific progenitors from retinal precursor cells7
Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model7
Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT)7
Generation of human induced pluripotent stem cell lines (hiPSC) from one bipolar disorder patient carrier of a DGKH risk haplotype and one non-risk-variant-carrier bipolar disorder patient6
A pathway for attesting ethical provenance of cell lines: Lessons from the European human pluripotent stem cell registry (hPSCreg)6
Generation of induced pluripotent stem cell line (CSUXHi002-A) from a patient with spinocerebellar ataxia type 16
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation6
Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editing6
Derivation of a human induced pluripotent stem cell line (QBRIi007-A) from a patient carrying a homozygous intronic mutation (c.613-7T>G) in the SLC2A2 gene6
Generation of human iPS cell line ihFib3.2 from dermal fibroblasts6
Generation of integration-free induced pluripotent stem cell lines from four pediatric ADHD patients6
Viral-free generation and characterization of a human induced pluripotent stem cell line from dermal fibroblasts6
Generation of iPSC lines from a Nijmegen Breakage Syndrome patient6
Generation of human pluripotent stem cell lines (iPSCs) from mesenchymal stem cells (MSCs) from three elderly patients with osteoarthritis6
Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant6
Generation and characterization of human iPSC line from CD34 + cells isolated from umbilical cord blood belonging to Indian origin6
Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene6
Generation of an induced pluripotent stem cell line (XHCSUi001-A) from urine cells of a patient with spinocerebellar ataxia type 36
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage6
Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in S6
Human-induced pluripotent stem cell lines (CMCi006-A and CMCi007-A) from a female and male patient with Fabry disease carrying the same frameshift deletion mutation6
Derivation of human embryonic stem cell from spinal muscular atrophy patient6
Generation and characterization of induced pluripotent stem cell line (IGIBi001-A) from a sickle cell anemia patient with homozygous β-globin mutation6
Generation of two induced pluripotent stem cell (iPSC) lines from X-linked adrenoleukodystrophy (X-ALD) patients with adrenomyeloneuropathy (AMN)6
Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q11.2-q136
Establishment of induced pluripotent stem cell (iPSC) line from a 63-year old patient with late onset Alzheimer's disease (LOAD)6
Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene6
Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation6
Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 36
Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa6
Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome6
Improved methods for the differentiation of hypothalamic vasopressin neurons using mouse induced pluripotent stem cells6
Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing6
Generation of an iPS cell line via a non-integrative method using urine-derived cells from a patient with USH2A-associated retinitis pigmentosa6
Derivation of three induced pluripotent stem cell lines under feeder-free culture conditions from peripheral blood mononuclear cells (PBMC) of Indian patients suffering from inherited retinal diseases6
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation6
Reprogramming of mouse amniotic fluid cells using a PiggyBac transposon system6
Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with recessive dystrophic epidermolysis bullosa (RDEB) carrying two compound heterozygous mutations in the C6
Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral scl6
Generation of urine iPS cell line from a patient with obsessive-compulsive disorder using a non-integrative method6
Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy6
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 16
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Autosomal Recessive Osteopetrosis due to mutations in TCIRG1 gene.6
Induced pluripotent stem cell (iPSC) line from an epidermolysis bullosa simplex patient heterozygous for keratin 5 E475G mutation and with the Dowling Meara phenotype6
Generation of a human induced pluripotent stem cell line (VRFi001-A) from orbital adipose tissue of a bilateral retinoblastoma patient with heterozygous RB1 gene deletion6
Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts6
Derivation of functional insulin-producing cell lines from primary mouse embryo culture6
Generation of disease-specific and CRISPR/Cas9-mediated gene-corrected iPS cells from a patient with adult progeria Werner syndrome6
Generation of an induced pluripotent stem cell line (UNCCi002-A) from a healthy donor using a non-integration system to study Cerebral Cavernous Malformation (CCM)6
Generation of induced pluripotent stem cell line (ZZUi005-A) from a 21-year-old patient with a novel RAB39B gene mutation in X-linked juvenile parkinsonism6
Three lines of induced pluripotent stem cells derived from a 15q11.2-q13.1 duplication syndrome patient6
LIF-dependent primitive neural stem cells derived from mouse ES cells represent a reversible stage of neural commitment6
Generation of induced pluripotent stem cell line from foreskin fibroblasts6
Generation of an induced pluripotent stem cell cohort suitable to investigate sporadic Alzheimer's Disease6
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation6
Generation of an iPS cell line from bone marrow derived mesenchymal stromal cells from an elderly patient6
Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD16
Neurogenic potential of hESC-derived human radial glia is amplified by human fetal cells6
Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation6
Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.6
Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient6
Characterization of human induced pluripotent stem cell (iPSC) line from a 72 year old male patient with later onset Alzheimer's disease6
Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier6
Extractive from Hypericum ascyron L promotes serotonergic neuronal differentiation in vitro6
Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX16
Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene5
Generation of two hiPSC clones (MHHi019-A, MHHi019-B) from a primary ciliary dyskinesia patient carrying a homozygous deletion in the NME5 gene (c.415delA (p.Ile139Tyrfs*8))5
Generation of a human induced pluripotent stem cell line (CPGHi001-A) from a hearing loss patient with the TMC1 p.M418K mutation5
Establishment of an iPSC line (JTUi002-A) from a patient with Waardenburg syndrome caused by a SOX10 mutation and carrying a GJB2 mutation5
Generation of iPSC line from desmin-related cardiomyopathy patient carrying splice site mutation of DES gene5
Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 65
Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson’s disease patient carrying the heterozygous p.A30P mutation in SNCA5
Fibronectin-conjugated thermoresponsive nanobridges generate three dimensional human pluripotent stem cell cultures for differentiation towards the neural lineages5
Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation5
Human pluripotent stem cell line (HDZi001-A) derived from a patient carrying the ARVC-5 associated mutation TMEM43-p.S358L5
Direct induction of functional neuronal cells from fibroblast-like cells derived from adult human retina5
Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation5
Generation of an integration-free induced pluripotent stem cell line, FJMUi001-A, from a hereditary spastic paraplegia patient carrying compound heterozygous p.P498L and p.R618W mutations in CAPN1 (SP5
Generation of induced pluripotent stem cells MMCi001-A from a Taiwanese hearing loss patient carrying GJB2 pV37I mutation5
Generation of a human iPSC line from an epileptic encephalopathy patient with electrical status epilepticus during sleep carrying KCNA2 (p.P405L) mutation5
Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations5
Generation of a gene-corrected human induced pluripotent stem cell line derived from a patient with laterality defects and congenital heart anomalies with a c.455G > A alteration in DAND5.5
Derivation of two naturally isogenic iPSC lines (KAUSTi006-A and KAUSTi006-B) from a mosaic Klinefelter Syndrome patient (47-XXY/46-XY)5
Generation of human induced pluripotent stem cells from individuals with a homozygous CCR5Δ32 mutation5
Generation of six human iPSC lines from patients with a familial Alzheimer’s disease (n = 3) and sex- and age-matched healthy controls (n = 3)5
Derivation, characterization, and gene expression profile of two new human ES cell lines from India5
Characterization of the first induced pluripotent stem cell line generated from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia due to a heterozygous mutation i5
Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene5
Calreticulin regulates Src kinase in osteogenic differentiation from embryonic stem cells5
Generation of human iPS cell line IBCHi001-A from dentatorubral–pallidoluysian atrophy patient's fibroblasts5
Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene5
Derivation of iPSC lines from two patients with familial Alzheimer's disease from India5
Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation5
Induced pluripotent stem cell line from an atopic dermatitis patient heterozygous for c.2282del4 mutation in filaggrin: KCLi001-A5
Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD)5
Generation of a transgene-free human induced pluripotent stem cell line (UNIPDi001-A) from oral mucosa epithelial stem cells5
Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson’s disease5
Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 35
Generation of two Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD02 and DMD03 (MUNIi001-A and MUNIi003-A)5
Corrigendum to “Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line” [Stem Cell Res. 34/1873–5061 (2019) 101349–55]5
Generation of two NAGLU-mutated homozygous cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo B syndrome5
Sufficiency of hypoxia-inducible 2-oxoglutarate dioxygenases to block chemical oxidative stress-induced differentiation of human embryonic stem cells5
Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance5
Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects5
Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75 year old female5
Generation of a clonal induced pluripotent stem cell (iPSC) line expressing the mutant MECP2 allele from a Rett Syndrome patient fibroblast line5
Generation of genetically matched hiPSC lines from two mosaic facioscapulohumeral dystrophy type 1 patients5
Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene5
Generation of integration-free induced pluripotent stem cells from healthy individuals5
Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene5
Blood-derived integration-free iPS cell line UKBi011-A from a diagnosed male Alzheimer's disease patient with APOE ɛ4/ɛ4 genotype5
Isolation of muscle stem cells from rat skeletal muscles5
Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene5
Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation5
Generation of a homozygous HDAC6 knockout human embryonic stem cell line by CRISPR/Cas9 editing5
Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease5
Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation5
Generation of two induced pluripotent stem cell lines IMAGINi004-A and IMAGINi005-A from healthy donors5
Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B5
Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control5
Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease5
Establishment of induced pluripotent stem cell (iPSC) line from an 84-year old patient with late onset Alzheimer's disease (LOAD)5
Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population5
Generation of a human iPSC line from a patient with a defect of intergenomic communication5
Generation of an induced pluripotent stem cell line from chorionic villi of a Patau syndrome spontaneous abortion5
Generation of the Niemann–Pick type C2 patient-derived iPSC line AKOSi001-A5
Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia5
Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia5
Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus5
Generation of two human induced pluripotent stem cell lines derived from two juvenile nephronophthisis patients with NPHP1 deletion5
Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling5
Generation of the human induced pluripotent stem cell line (UKWNLi001-A) from skin fibroblasts of a woman with Fabry disease carrying the X-chromosomal heterozygous c.708 G > C (W236C) missense mut5
Functional video-based analysis of 3D cardiac structures generated from human embryonic stem cells5
Generation of two induced pluripotent stem cell lines (MUSIi011-A and MUSIi011-B) from peripheral blood T lymphocytes of a healthy individual5
Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS355
Reliable generation of glial enriched progenitors from human fibroblast-derived iPSCs5
Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation5
Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease5
The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line5
Establishment of three iPSC lines from fibroblasts of a patient with Aicardi Goutières syndrome mutated in RNaseH2B5
Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system5
6.0476939678192